The core idea behind these smart probes is elegantly simple: keep the magnetic signal silent during circulation in the bloodstream, and switch it on only when the nanoparticle encounters the distinctive chemistry of a tumor. Solid tumors are not just lumps of dividing cells; they are microenvironments with their own abnormal physics and biochemistry. The Warburg effect drives extracellular acidity, with tumor tissue sitting at a pH of roughly 6.5 to 6.8 compared with 7.4 in healthy tissue. Mitochondrial dysfunction floods the region with reactive oxygen species and elevated glutathione. Overactive enzymes such as matrix metalloproteinases chew through surrounding matrix. Each of these anomalies is a potential trigger, and researchers are engineering nanoscale coordination polymers, self-assembled micelles, and core-shell particles that act like logic gates, computing multiple microenvironment inputs before delivering a high-fidelity imaging output.

The review, spanning advances reported between 2023 and 2026, organizes the field around several material families. Gadolinium- and manganese-based platforms dominate T1-weighted imaging, where ultrasmall nanoparticles maximize surface water exchange and thus longitudinal relaxivity. The most clinically advanced of these is AGuIX, a roughly five-nanometer gadolinium-polysiloxane nanoparticle that combines strong T1 contrast with radiosensitizing capability and, critically, efficient renal clearance. Manganese offers a compelling alternative: manganese dioxide nanosheets remain stable in blood but are reduced to freely relaxing Mn2+ ions in the glutathione-rich, acidic tumor environment, generating activatable T1 signal from a biologically metabolizable metal.

On the T2 side, superparamagnetic iron oxide nanoparticles remain the most widely investigated platform, and their clinical story is already written. Ferumoxytol, an FDA-approved intravenous iron formulation, has been used off-label for years as an MRI contrast agent in brain tumors, bone metastases, and liver malignancies. At clinical doses of 3 to 7 milligrams of iron per kilogram, it is well tolerated, and its strong T2 contrast at 3 Tesla allows sensitive visualization of tumor vasculature and inflammatory infiltration. What makes ferumoxytol especially interesting is its preferential uptake by macrophages, particularly M2-like tumor-associated macrophages, which effectively turns it into a noninvasive surrogate of the tumor immune microenvironment rather than a simple perfusion marker.

Beyond the metal-based workhorses, the review highlights two emerging modalities that promise background-free, quantitative molecular imaging. Chemical exchange saturation transfer, or CEST, nanoplatforms embed exchangeable protons into nanoliposomes, polymeric microcapsules, and metal-organic frameworks, enabling spectrally selective detection of pH and enzyme activity. Fluorine-19 MRI goes further: because the human body contains almost no mobile fluorine, perfluorocarbon nanoemulsions produce images with literally zero background signal. Supramolecular assembly-disassembly strategies now allow 19F probes to remain off until they encounter cancer-associated biomarkers such as microRNA, ATP, thrombin, or telomerase, restoring signal only at the disease site. Meanwhile, entirely metal-free probes based on nitroxide radicals, carbon dots, and graphene quantum dots are being developed to sidestep heavy-metal toxicity altogether, though their rapid in vivo reduction and limited relaxivity remain engineering challenges.

The activation mechanisms themselves reveal how sophisticated these designs have become. pH-activated platforms exploit tumor acidity to cleave boronate-ester linkages, decompose gadolinium oxide nanosheets, or trigger drug release, with one ovarian cancer nanotheranostic achieving five-fold stronger imaging signals and an 80 percent complete-cure rate in preclinical models. Redox-responsive systems take advantage of the tumor’s altered redox balance: manganese dioxide-coated nanoprobes decompose in glutathione-rich conditions, releasing Mn2+ that is then captured by albumin in the tumor stroma to form a high-relaxivity complex, a cascade the authors of one study call holographic activation. Enzyme-triggered probes respond to tumor-associated nucleic acid signatures, with DNAzyme-activated manganese carbonate nanoparticles releasing 90 percent of their Mn2+ payload within an hour in acidic conditions, and azoreductase-activated magnetic resonance energy transfer probes flipping from an off to an on state only in tumors with high enzyme expression.

Perhaps the most consequential shift described in the review is the move from tumor-centric imaging toward mapping the tumor immune microenvironment. Immunotherapy has reshaped oncology, but distinguishing true therapeutic response from pseudoprogression remains a clinical headache. MRI strategies that visualize and quantify immune and stromal cells, including tumor-associated macrophages, T lymphocytes, dendritic cells, and cancer-associated fibroblasts, are emerging as a bridge between noninvasive imaging and response assessment. Multiparametric CEST MRI has detected metabolic changes in breast cancer following checkpoint inhibitor therapy before any morphological change appeared. A nitric oxide-responsive magnetic probe based on crosslinked iron oxide nanoparticles achieved a detection limit as low as 0.147 micromolar, allowing noninvasive visualization of M1 macrophage polarization, an early marker of immune activation. And SPION-labeled CAR-T cells have been tracked in vivo with magnetic particle imaging, showing antigen-specific accumulation in gastric tumors, while dextran-coated iron oxide labels have revealed that the spatial distribution of T cells within gliomas correlates with therapeutic outcome.

The theranostic dimension adds another layer of ambition. By integrating chemotherapeutics, photosensitizers, or photothermal agents directly into activatable MRI matrices, these platforms synchronize diagnosis and treatment, letting clinicians monitor drug release kinetics and assess efficacy in real time. A bismuth-substituted version of AGuIX preserves MRI contrast while amplifying radiation dose deposition under clinical megavoltage energies. A supramolecular dendrimer nanoprobe enabled pancreatic cancer detection at one-tenth the conventional gadolinium dose. An APE1-activatable afterglow/MRI probe predicted radiotherapy response within three hours by correlating signals with DNA damage markers. These are striking demonstrations, but the review is candid about the gap between bench and bedside: approximately 90 percent of nanocontrast agents remain stuck at the animal stage, and median nanoparticle delivery to solid tumors is below 1 percent of the injected dose, a sobering reminder that the enhanced permeability and retention effect is far more heterogeneous than once assumed.

The translational bottlenecks are as instructive as the successes. Gadolinium deposition in brain and bone tissue, even in patients with normal renal function, has intensified scrutiny of Gd-based agents, while manganese platforms face unresolved questions about dose-dependent accumulation and potential neurotoxicity. Manufacturing reproducibility is a major hurdle, since multistep syntheses involving responsive polymers, peptides, and nucleic acids produce batch-to-batch variation in particle size, relaxivity, and stimulus responsiveness. Regulatory agencies currently apply pharmaceutical standards to what are effectively drug-device hybrids, and the review argues that dedicated nanotheranostic guidelines are needed. Only a handful of platforms, chiefly AGuIX in Phase I/II trials for brain metastases and glioblastoma and ferumoxytol in off-label clinical use, have generated peer-reviewed human data, while newer systems such as magnetic hyperthermia platforms and USPIO-based diagnostic agents remain at the registration or feasibility stage.

Artificial intelligence may help close that gap. Machine learning is being deployed across the entire development pipeline, from predicting optimal nanoparticle compositions and surface chemistries before synthesis to decoding stimulus-induced signal changes, extracting radiomic features, and characterizing spatial heterogeneity of hypoxia and immune infiltration within tumors. The review’s authors are careful to note that AI’s clinical value ultimately depends on standardized imaging protocols, reproducible biomarkers, and biologically validated endpoints rather than purely data-driven correlations. Their overall message, however, is clear: activatable MRI nanoprobes represent not merely better contrast but a step toward biologically informed imaging readouts that can guide treatment stratification, monitor immunotherapy in real time, and ultimately turn MRI into an intelligent imaging drug for precision oncology. The chemistry is largely in place; the remaining challenge is proving that these clever machines can be manufactured, regulated, and delivered well enough to matter in the clinic.

Subject of Research: Activatable MRI nanoprobes for tumor and immune microenvironment imaging

Article Title: Activatable MRI nanoprobes for tumor and immune microenvironment imaging: biological mechanisms and translational implications

Article References: Wang, K., Wei, Z., Lu, X., & Wang, S. (2026). Activatable MRI nanoprobes for tumor and immune microenvironment imaging: biological mechanisms and translational implications. Materials Today Bio, 41, Article 103717. https://doi.org/10.1016/j.mtbio.2026.103717

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103717

Keywords: MRI nanoprobes, tumor microenvironment, contrast agents, immunotherapy imaging, theranostics, gadolinium, manganese, ferumoxytol, fluorine-19 MRI, CEST, machine learning, clinical translation

High-moisture extrusion is the industrial workhorse behind most plant-based meat alternatives. A protein dough, typically derived from soy or pea isolates, is hydrated, mixed and then pushed through a heated barrel where temperatures reach 135 degrees Celsius and intense shear forces from co-rotating screws knead the material. The molten protein then passes through a cooling die, where it solidifies into a ribbon with a lamellar, fibrous structure reminiscent of muscle tissue. The critical question has always been how this hierarchical anisotropy forms: which processes happen in the barrel, which in the cooling die, and how events at the nanometre scale cascade upward to determine the texture a consumer actually perceives when chewing.

To answer this, the researchers deployed an unusually broad arsenal of magnetic resonance methods. T2-weighted MRI at 14 tesla visualised the phase-separated architecture, distinguishing protein-rich domains from water-rich lamellae at the hundred-micrometre scale. Diffusion tensor MRI, a technique borrowed from clinical neuroimaging where it maps white matter tracts, was used to measure the directionality of water self-diffusion within each voxel, revealing the orientation of structures far below the imaging resolution. Chemical exchange saturation transfer MRI, performed at the extraordinary field strength of 28.2 tesla, probed the chemical composition of the two phases, detecting mobile proteins dissolved in the water-rich regions through their amide and relayed nuclear Overhauser enhancement signatures.

The team extruded commercial soy protein concentrate at 60 percent moisture and shifted the pH of the feed liquid to three values: acidic pH 5.0, near the isoelectric point of the protein; neutral pH 7.0; and alkaline pH 7.8. The results were striking. At neutral and alkaline pH, the extrudates displayed beautifully aligned lamellar structures running parallel to the extrusion direction, with weighted order parameters reaching 0.9 in sagittal views. At pH 5.0, by contrast, the macroscopic lamellar order collapsed almost entirely, with order parameters dropping to around 0.4 and no uniform aligned phase separation visible along the flow direction.

Yet the story at smaller length scales was inverted. Confocal laser scanning microscopy, capable of resolving features down to roughly 100 nanometres, showed that the acidic sample actually possessed a well-aligned fibrillar protein network at the sub-micrometre scale, with order parameters around 0.6, comparable to the neutral sample. The alkaline sample, meanwhile, lacked this fine-scale fibrillar alignment altogether, a consequence of strong electrostatic repulsion between highly charged protein fibrils far from their isoelectric point. This decoupling between order at different scales provided the central clue to the mechanism of structure formation.

The diffusion tensor measurements added quantitative weight to this picture. In the protein-rich lamellae of the pH 7.0 sample, water diffused preferentially along the extrusion direction, the fastest diffusion direction coinciding with the shear imposed by the extruder screws, while the slowest diffusion ran perpendicular to the lamellae. Fractional anisotropy values of about 0.3 in the protein-rich phase, against 0.2 in the water-rich phase, confirmed that the aligned protein fibrils observed microscopically were genuinely hindering water motion in a directional manner. Because the diffusion encoding time of 50 milliseconds probes water displacement over roughly 9 to 33 micrometres, the technique effectively senses the cumulative effect of countless sub-micrometre fibrils, bridging the gap between what microscopy and conventional MRI can each see.

To understand why the cooling die geometry matters, the researchers generated synthetic axial MRI images mimicking lamellar patterns for four die cross-sections: elliptical, bullnose, rounded-rectangle and sharp-cornered rectangular. The rotated Fourier transform analysis, a recently developed image-processing method that extracts orientational order from two-dimensional images, showed that elliptical dies produce highly homogeneous order parameters near 0.93, while progressively sharper corners carve out increasingly wide zones of disorder, with order parameters falling to 0.3 in the corners of the sharpest geometry. The experimental maps of real extrudates matched the sharp-cornered simulation almost exactly, with a disordered corner region roughly 1.5 millimetres wide, demonstrating that the die’s shape directly imprints its geometry onto the internal texture of the product.

Synthesising these observations, the authors propose a two-stage mechanism. Fibril formation and alignment at the sub-micrometre scale begin already in the extruder barrel and transition zone. The degree of this fine-scale alignment, governed by pH through electrostatic screening, then controls the rheology of the protein melt entering the cooling die. At pH 5.0, the strongly aligned fibrillar network raises the yield stress so much that the melt can no longer flow in laminar sheets through the die, and the macroscopic lamellar structure fails to form. At pH 7.8, weak fibril alignment keeps the yield stress low, allowing coarse lamellae to form but without the underlying fibrillar backbone. Only at an intermediate pH, where fibrillar alignment and electrostatic repulsion strike a balance, do both levels of hierarchy emerge in concert. As a compelling validation of the method’s specificity, the team showed that commercial high-moisture mozzarella, whose casein structure is aligned only by stretching at much lower temperatures, exhibits order at the hundred-micrometre scale but no diffusional anisotropy at smaller scales, consistent with small-angle neutron scattering showing isotropy below 90 nanometres.

The implications reach well beyond academic curiosity. Plant-based meat alternatives are a cornerstone of the protein transition, yet their texture remains the chief barrier to consumer acceptance. By establishing high-resolution MRI, diffusion tensor imaging and CEST as a versatile, non-destructive toolkit for quantifying hierarchical anisotropy in intact extrudates, the study gives food engineers, for the first time, a way to watch structure form across six orders of magnitude in length scale and to rationally tune pH, die geometry and processing conditions. The work was funded by the Dutch Research Council together with industrial partners including Unilever, Cargill, dsm-firmenich and FrieslandCampina, underscoring the commercial stakes. If the meat-like fibrousness of the next generation of plant-based products improves noticeably, it may well be because a scanner originally built for brains taught manufacturers how to build better fibres.

Subject of Research: Magnetic resonance imaging of hierarchical anisotropic structure formation in high-moisture soy protein extrudates

Article Title: Underpinning hierarchical anisotropic structure formation in soy protein high-moisture extrudates by Magnetic Resonance Imaging

Article References: Kuijpers, S. A., Gobes, M. I., Mayar, M., Vergeldt, F. J., Hohlbein, J., Huppertz, T., van Duynhoven, J. P., & Terenzi, C. (2026). Underpinning hierarchical anisotropic structure formation in soy protein high-moisture extrudates by Magnetic Resonance Imaging. Current Research in Food Science, 13, Article 101575. https://doi.org/10.1016/j.crfs.2026.101575

Image Credits: AI Generated

DOI: Not provided

Keywords: plant-based meat, high-moisture extrusion, soy protein, MRI, diffusion tensor imaging, CEST, food structure, anisotropy, pH-shifting, cooling die geometry, confocal microscopy, food science